Developments in Neuromodulation Therapies 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Developments in Neuromodulation Therapies" report to their offering.

This edition of FT TOE covers technological developments and commercial implications of various neuromodulation therapies that are redefining the standard of care offered by traditional drug-based therapies. The issue covers a snapshot of the global neuromodulation industry, highlighting the intensity of research and commercial prospects for newer clinical applications of these therapies. Detailed analysis of the market and technological drivers and challenges are covered, along with their influence on value of care offered to patients. The issue covers four innovation portfolios within this technology sector, including information and analyst insights on potential business models that could redefine healthcare.

The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world.

Key Topics Covered:

1. Industry Snapshot of Neuromodulation Therapies

Most Prescribed Neuromodulation Therapies Target Low Back Pain

The Clinical Utilization of Neuromodulators is Extending the Way Patients Undertake Therapies

OEM Efforts to Expand Marketing Channels Are Focused on Widening Clinical Applications

Demand for Precise Innervation Triggers Initiatives for Improved Design of Stimulation Leads

Entry of New Participants with Innovative Technologies Affects Pipeline of OEMs

2. Key Technology Developments in Neuromodulation Therapies

Coin-sized Bioelectronic Device for Chronic Conditions

Implantable Neuromodulation Therapy for Inflammatory Diseases

Implantable Neuromodulator for Heart Failure and Hypertension

Cardiac Contractility Modulation for Chronic Heart Failure

3. IP Landscape of Neuromodulation Therapies

The United States has Top Rated Jurisdiction for Patents on Neuromodulation Therapies

Optogenetic Therapies for Movement Disorders

Implantable Medical Device having a Conducive Coating

4. Analyst Insights

Demand for Non-invasive and Collaborative Care Drive Technology-enabled Business Models

OEMs Need to Transfer Cost Savings across the Value Chain when Evaluating Global Growth Strategies

5. Key Contacts

For more information about this report visit http://www.researchandmarkets.com/research/rz4ht4/developments_in.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices